March 2019 FDA Recall Gavilyte-n by Lupin Somerset
D-1113-2019 - Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient

This Class II drug recall was voluntarily initiated by Lupin Somerset on March 19, 2019 for the product Gavilyte-n. The FDA reported the reason for recall as labeling not elsewhere classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1113-2019

Reason for Recall
Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient
Initiated
03-19-2019
Reported
04-17-2019
Quantity
76422 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Gavilyte-N, PEG-3350, Sodium chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution, Rx only, Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD NDC 43386-050-19 UPC 343386050192 a) Lemon Flavor Pack net wt. 2 g UPC 343386200023 b) Orange Flavor Pack net wt. 2 g UPC 343386202027 c) Cherry Flavor Pack net wt. 2 g UPC 3433862034

Batch or Lot Expiration Information

Lot# : a) S800021, Exp 30-Nov-20; b) S800175, Exp 31-Dec-20; c) S 800401, Exp 28-Feb-21; S800426, Exp 31-Mar-21; S800920, Exp 31-Aug-21.

Affected Packages Involved in this Recall